|
Market Closed -
NYSE
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.670 USD | +1.91% |
|
+5.12% | +48.33% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 215M 185M 174M 159M 298M 20.31B 298M 2.06B 799M 10.42B 808M 790M 33.57B | P/E 2026 * |
14.1x | P/E 2027 * | 48.5x |
|---|---|---|---|---|---|
| Enterprise Value | 215M 185M 174M 159M 298M 20.31B 298M 2.06B 799M 10.42B 808M 790M 33.57B | EV / Sales 2026 * |
2.7x | EV / Sales 2027 * | 3.15x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
Tradegate
| PBDA | Real-time | |
Börse Stuttgart
| PBDA | Delayed | |
Deutsche Boerse AG
| PBDA | Delayed | |
Boerse Muenchen
| PBDA | Real-time |
Last Transcript : Protalix BioTherapeutics, Inc.
| 1 day | +1.91% | ||
| 1 week | +5.12% | ||
| Current month | +3.89% | ||
| 1 month | +12.66% | ||
| 3 months | +32.84% | ||
| 6 months | -5.65% | ||
| Current year | +48.33% |
| 1 week | 2.52 | 2.68 | |
| 1 month | 2.17 | 2.7 | |
| Current year | 1.72 | 3.19 | |
| 1 year | 1.53 | 3.19 | |
| 3 years | 0.82 | 3.19 | |
| 5 years | 0.7 | 3.55 | |
| 10 years | 0.7 | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 03/09/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 03/09/26 | Free | Chief Executive Officer | 480,000 | 0.5957% | ||
| 03/09/26 | Free | Director | 25,500 | 0.0316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.91% | +5.12% | +67.92% | +34.85% | 215M | ||
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | ||
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | ||
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | ||
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | ||
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | ||
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | ||
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | ||
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | ||
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | ||
| Average | -0.70% | +1.50% | +32.26% | +49.50% | 367.86B | |
| Weighted average by Cap. | -1.10% | +0.55% | +36.62% | +66.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.8M 68.66M 64.6M 59.02M 110M 7.53B 111M 763M 296M 3.87B 300M 293M 12.45B | 68.19M 58.68M 55.21M 50.44M 94.35M 6.44B 94.61M 652M 253M 3.3B 256M 250M 10.64B |
| Net income | 15.38M 13.23M 12.45M 11.37M 21.27M 1.45B 21.33M 147M 57.08M 745M 57.73M 56.48M 2.4B | 4.46M 3.84M 3.61M 3.3M 6.17M 421M 6.19M 42.7M 16.57M 216M 16.76M 16.39M 696M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $2.670 | +1.91% | 863,718 |
| 03/09/26 | $2.620 | +1.16% | 942,012 |
| 02/09/26 | $2.590 | 0.00% | 454,863 |
| 01/09/26 | $2.590 | +0.78% | 598,262 |
| 31/08/26 | $2.570 | +1.18% | 748,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions

















